Research output per year
Research output per year
Personal profile
Expertises
Lung cancer; Neuroendocrine tumors; Bronchopulmonary neuroendocrine tumors; Malignant mesotheliomas; Extravasation of chemotherapy; Exercise intervention in cancer patients; Predictive and prognostic markers in cancer, Clinical nuclear imaging in oncology; Anti cancer drug development.
Main research areas
Clinical phase 2 and 3 therapeutic trials in lung cancer and neuroendocrine carcinomas; Pre- and postoperative excercise intervention studies in lung cancer; Epidemiological, demographic, clinical and translational studies of neuroendocrine carcinomas and bronchopulmonary neuroendocrine tumors; Early response evaluation in lung cancer and neuroendocrine tumors by different nuclear imaging (PET-) tracers and molecular markers; Translational studies of extravastion of chemotherapy.
Current research
Clinical phase 2 and 3 therapeutic trials in lung cancer and neuroendocrine carcinomas; Pre- and postoperative excercise intervention studies in lung cancer; Epidemiological, demographic, clinical and translational studies of neuroendocrine carcinomas and bronchopulmonary neuroendocrine tumors; Early response evaluation in lung cancer and neuroendocrine tumors by nuclear imaging (PET-) tracers and molecular markers. Prognostic and predictive value of immunomarkers in lung cancer
Potential conflicts of interest
None
External positions
Associate Professor, Department of Clinical Medicine, University of Copenhagen
Fingerprint
Dive into the research topics where Seppo Wang Langer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Appendiceal Neuroendocrine Neoplasms: an Update for 2023
Holmager, P., Langer, S. W., Kjaer, A., Ringholm, L., Garbyal, R. S., Hansen, C. P., Andreassen, M. & Knigge, U., Feb 2024, In: Current Oncology Reports. 26, 2, p. 114-120 7 p.Research output: Contribution to journal › Review › peer-review
2 Citations (Scopus) -
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Perrone, E., Ghai, K., Eismant, A., Andreassen, M., Langer, S. W., Knigge, U., Kjaer, A. & Baum, R. P., 26 Apr 2024, In: Diagnostics. 14, 9, 907.Research output: Contribution to journal › Journal article › Research › peer-review
-
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
Sorbye, H., Hjortland, G. O., Vestermark, L. W., Sundlov, A., Assmus, J., Couvelard, A., Perren, A. & Langer, S. W., 27 Jun 2024, (E-pub ahead of print) In: Journal of Neuroendocrinology. p. e13428Research output: Contribution to journal › Journal article › Research › peer-review
-
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease
Slott, C., Langer, S. W., Møller, S., Krogh, J., Klose, M., Hansen, C. P., Kjaer, A., Holmager, P., Garbyal, R. S., Knigge, U. & Andreassen, M., 1 Jan 2024, In: Cancers. 16, 1, 204.Research output: Contribution to journal › Journal article › Research › peer-review
-
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms
Soldath, P., Binderup, T., Kjaer, A., Knigge, U., Langer, S. W. & Petersen, R. H., 1 Feb 2024, In: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 65, 2, ezae030.Research output: Contribution to journal › Journal article › Research › peer-review